An assay based on gold nanoparticles could detect recurrences of prostate cancer sooner than is possible with existing techniques.
References
Freedland, S. J. & Moul, J. W. J. Urol. 177, 1985–1991 (2007).
Thaxton, C. S. et al. Proc. Natl Acad. Sci. USA 106, 18437–18442 (2009).
Barry, M. J. N. Engl. J. Med. 360, 1351–1354 (2009).
Healy, D. A. et al. Trends Biotechnol. 25, 125–131 (2007).
Thompson, I. M. et al. J. Natl Cancer Inst. 98, 529–534 (2006).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hearty, S., Leonard, P. & O'Kennedy, R. Barcodes check out prostate cancer. Nature Nanotech 5, 9–10 (2010). https://doi.org/10.1038/nnano.2009.459
Issue Date:
DOI: https://doi.org/10.1038/nnano.2009.459
- Springer Nature Limited
This article is cited by
-
DNA-framework-based multidimensional molecular classifiers for cancer diagnosis
Nature Nanotechnology (2023)
-
Aberrant PSA glycosylation—a sweet predictor of prostate cancer
Nature Reviews Urology (2013)